GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » PB Ratio

BioLight Life Sciences (BioLight Life Sciences) PB Ratio : 246.97 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), BioLight Life Sciences's share price is $32.60. BioLight Life Sciences's Book Value per Share for the quarter that ended in Dec. 2023 was $0.13. Hence, BioLight Life Sciences's PB Ratio of today is 246.97.

The historical rank and industry rank for BioLight Life Sciences's PB Ratio or its related term are showing as below:

BOLT' s PB Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.71   Max: 9.09
Current: 0.53

During the past 12 years, BioLight Life Sciences's highest PB Ratio was 9.09. The lowest was 0.03. And the median was 0.71.

BOLT's PB Ratio is ranked better than
91.06% of 1309 companies
in the Biotechnology industry
Industry Median: 2.38 vs BOLT: 0.53

During the past 12 months, BioLight Life Sciences's average Book Value Per Share Growth Rate was -45.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -21.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -19.20% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of BioLight Life Sciences was 98.20% per year. The lowest was -73.70% per year. And the median was -15.45% per year.

Back to Basics: PB Ratio


BioLight Life Sciences PB Ratio Historical Data

The historical data trend for BioLight Life Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences PB Ratio Chart

BioLight Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioLight Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioLight Life Sciences's PB Ratio

For the Biotechnology subindustry, BioLight Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLight Life Sciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's PB Ratio falls into.



BioLight Life Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

BioLight Life Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=32.60/0.132
=246.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


BioLight Life Sciences  (NAS:BOLT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


BioLight Life Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences (BioLight Life Sciences) Business Description

Traded in Other Exchanges
Address
Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101
BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences (BioLight Life Sciences) Headlines

From GuruFocus

Bolt Biotherapeutics Appoints Laura Berner to Board of Directors

By Value_Insider Value_Insider 12-14-2022